Effect of High Stanol Ester Dose on Serum Lipids, Carotenoids and Fat-soluble Vitamins (maxsta)
Primary Purpose
Hypercholesterolemia
Status
Completed
Phase
Not Applicable
Locations
Finland
Study Type
Interventional
Intervention
vegetable oil-based spread and oat-based drink (no brand name available)
vegetable oil-based spread and oat-based drink (no brand name available)
Sponsored by
About this trial
This is an interventional supportive care trial for Hypercholesterolemia
Eligibility Criteria
Inclusion Criteria:
- Total cholesterol 4.5-7.5 mmol/l)
- Age 18-75 years
Exclusion Criteria:
- Liver, kidney and thyroid dysfunction
- Unstable coronary disease
- Inflammatory bowel disease
- Medication for hypercholesterolemia
- Plant stanol/sterol enriched foods
Sites / Locations
- University of kuopio
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Placebo Comparator
Arm Label
1
2
Arm Description
Outcomes
Primary Outcome Measures
Serum lipids, Serum fat soluble vitamins and carotenoids, squalene and non-cholesterol sterols
Secondary Outcome Measures
Full Information
NCT ID
NCT00698256
First Posted
June 12, 2008
Last Updated
April 16, 2012
Sponsor
Marjukka Kolehmainen
Collaborators
Raisio Plc
1. Study Identification
Unique Protocol Identification Number
NCT00698256
Brief Title
Effect of High Stanol Ester Dose on Serum Lipids, Carotenoids and Fat-soluble Vitamins
Acronym
maxsta
Official Title
Effect of High Stanol Ester Dose on Serum Lipids, Carotenoids and Fat-soluble Vitamins
Study Type
Interventional
2. Study Status
Record Verification Date
April 2012
Overall Recruitment Status
Completed
Study Start Date
February 2008 (undefined)
Primary Completion Date
May 2008 (Actual)
Study Completion Date
December 2008 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Marjukka Kolehmainen
Collaborators
Raisio Plc
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The aim was to investigate the effects of the consumption of high doses of plant stanol esters on concentrations of serum lipids, carotenoids and fat soluble vitamins. In addition, we investigated the metabolism of absorbed plant sterols from intestine without and with the consumption of plant stanol esters.
Detailed Description
Several studies have shown that 2-3 g of plant stanols as stanol esters reduce serum total and LDL cholesterol concentrations by 10-15%. There are only a few studies in which cholesterol-lowering effects of plant stanols have been studied with higher doses than that. In these studies with the stanol dose of 4 g/d no additional cholesterol-lowering effect has been reached. However, it would be interesting to know, how effective plant stanols are, if a dose is very high, or whether there is really a threshold effect in inhibition of cholesterol absorption. Plant sterols and stanols have been found to reduce serum β-carotene concentrations. Although they have not been shown to affect serum vitamin A concentrations, a concern has been aroused about safety of high doses of plant sterol and stanols. This is not unjustified, because the number of plant sterol and stanol containing products on the market continues to expand, and therefore, it is possible that the daily intake of plant sterols and stanols can rise very high.
In humans, the metabolism of plant sterols and stanols is not completely known. Recently, we showed that plant sterols are esterified in enterocytes as well as cholesterol facilitating their transport in lipoproteins. However, it is not known, how consumption of high doses of stanol esters affect the metabolism of plant sterols in enterocytes and their transport. This is important to know, when new foodstuffs enriched with plant sterols or stanols for cholesterol-lowering are developed.
In this study, the aim was to investigate the effects of the consumption of high doses of plant stanol esters on concentrations of serum lipids, carotenoids and fat soluble vitamins. In addition, we investigated the metabolism of absorbed plant sterols from intestine without and with the consumption of plant stanol esters.
Altogether 50 subjects with normo- or hypercholesterolemia (total cholesterol 4.5-7.5 mmol/l) were recruited to the study from an announcement in the local newspaper. The study is carried out with a randomized, double-blind and parallel design. The intervention group (n=25) consumes spread and oat drink enriched with plant stanol esters (9 g/d stanols) and the control group (n=25) the same product containing no added stanols for 10 weeks. The fasting blood samples are taken at weeks 0, 9, 10 and 14 (4 weeks after the end of the test product consumption). At week 10, an oral postprandial test is performed in 40 subjects in order to study the postprandial metabolism of plant sterols. From blood samples blood count and levels of serum liver enzymes (0 and 10 wk), concentrations of serum lipids, squalene and non-cholesterol sterols, α and β carotenoids, fat soluble vitamins A, E and D (0, 9 and 10 wk) and serum squalene and non-cholesterol sterols (14 wk) will be analyzed.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hypercholesterolemia
7. Study Design
Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
50 (Actual)
8. Arms, Groups, and Interventions
Arm Title
1
Arm Type
Experimental
Arm Title
2
Arm Type
Placebo Comparator
Intervention Type
Dietary Supplement
Intervention Name(s)
vegetable oil-based spread and oat-based drink (no brand name available)
Intervention Description
spread and drink (9 g stanols/d)
Intervention Type
Dietary Supplement
Intervention Name(s)
vegetable oil-based spread and oat-based drink (no brand name available)
Intervention Description
Spread and drink (not containing added stanols)
Primary Outcome Measure Information:
Title
Serum lipids, Serum fat soluble vitamins and carotenoids, squalene and non-cholesterol sterols
Time Frame
baseline, at weeks 9, 10 and 14
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Total cholesterol 4.5-7.5 mmol/l)
Age 18-75 years
Exclusion Criteria:
Liver, kidney and thyroid dysfunction
Unstable coronary disease
Inflammatory bowel disease
Medication for hypercholesterolemia
Plant stanol/sterol enriched foods
Facility Information:
Facility Name
University of kuopio
City
Kuopio
ZIP/Postal Code
70211
Country
Finland
12. IPD Sharing Statement
Citations:
PubMed Identifier
24766766
Citation
Hallikainen M, Simonen P, Gylling H. Cholesterol metabolism and serum non-cholesterol sterols: summary of 13 plant stanol ester interventions. Lipids Health Dis. 2014 Apr 27;13:72. doi: 10.1186/1476-511X-13-72.
Results Reference
derived
PubMed Identifier
19709787
Citation
Gylling H, Hallikainen M, Nissinen MJ, Miettinen TA. The effect of a very high daily plant stanol ester intake on serum lipids, carotenoids, and fat-soluble vitamins. Clin Nutr. 2010 Feb;29(1):112-8. doi: 10.1016/j.clnu.2009.08.005. Epub 2009 Aug 26.
Results Reference
derived
Learn more about this trial
Effect of High Stanol Ester Dose on Serum Lipids, Carotenoids and Fat-soluble Vitamins
We'll reach out to this number within 24 hrs